Optimize RV Follow-up Selective Site Pacing Clinical Trial

Status:	Completed
Conditions:	Cardiology
Therapuetic Areas:	Cardiology / Vascular Diseases
Healthy:	No
Age Range:	18 - Any
Updated:	2/17/2018
Start Date:	September 2009
End Date:	December 2011

The purpose of the Optimize RV Follow-Up study is to determine the long-term effect of
selective site pacing. Selective site pacing refers to which area of the right ventricle the
lead is placed. The goal of selective site pacing is to improve how the heart contracts when
paced.

The Optimize RV Follow-Up Selective Site Pacing Clinical Trial is open to subjects that were
previously enrolled in the Optimize RV Selective Site Pacing Clinical Trial.

Inclusion Criteria:

- Subjects enrolled in the Optimize RV study (version 3, dated 6 March 2007)

- Subjects or legal guardians who are willing and able to sign an Informed Consent (and
Authorization to use and Disclose Health Information Form, if applicable)

Exclusion Criteria:

- Subjects who have a device that was programmed outside the Optimize RV programming
requirements

- Subjects implanted with and implantable cardioverter-defibrillator (ICD) or cardiac
resynchronization therapy (CRT) device

- Subjects who are pregnant or nursing

We found this trial at

sites

Clinical Trial Facility in Nashville Tennessee

Nashville, Tennessee 37232

from

Nashville, TN